Endometriosis Isn't "Normal." It's a Disease. And one that needs to be diagnosed and treated.

For decades, endometriosis has been undiagnosed in millions of women who have lived with debilitating menstrual pain, digestive symptoms, chronic inflammation, and infertility. The result is that many spend years searching for answers, moving from one specialist to another, treating symptoms, and often not receiving a diagnosis until they are trying to conceive or the disease has significantly progressed. What makes this particularly challenging is that endometriosis does not always present in obvious ways. Some women experience severe pain, while others have little to no symptoms despite extensive disease, making diagnosis based on symptoms alone incredibly difficult. This is why the emergence of reliable, non-invasive diagnostic tools like HerResolve by HerAnova represents such an important shift. These definitive results not only confirm the disease; they validate a woman’s experience that for too long have been minimized or dismissed as “normal”.

While mild discomfort during menstruation can be common, persistent or debilitating pain is not normal and warrants further investigation. Pain is the body’s way of signaling that something deserves attention. Ignoring the pain signal allows disease to progress.

To date the challenge had been that diagnosing and treating endometriosis required laparoscopic surgery. Because of this, countless women were left in diagnostic limbo, managing symptoms without ever knowing the cause. Some were treated for gastrointestinal disorders, others were referred for mental health concerns, and many simply continued living with unanswered questions while the disease progressed.

This is where advances in diagnostic technology have the potential to fundamentally change the patient experience. A non-invasive blood test capable of identifying biological markers associated with endometriosis offers the validation women have been waiting for. Providers can now begin making informed decisions earlier and can implement treatment strategies to lessen symptoms and possibly reverse the disease process.

Endometriosis is one of the leading contributors to infertility, affecting an estimated 40% of women experiencing infertility or unexplained infertility. Inflammation within the pelvic cavity can interfere with implantation, while advanced disease may create scar tissue and adhesions that alter normal pelvic anatomy. Identifying the disease, addressing inflammation and optimizing the pelvic and uterine environment before procedures such as embryo transfer help improve pregnancy outcomes.

Scientists do not believe there is a single cause of endometriosis. Retrograde menstruation had long been considered a possible explanation; however, nearly all women experience some degree of retrograde menstrual flow, yet only a fraction develop endometriosis. This suggests that genetics, immune function, inflammation, environmental exposures, and other biological mechanisms likely interact in ways that researchers are only beginning to understand. Rather than representing one disease with one pathway, endometriosis may actually describe several biological processes that produce similar clinical outcomes.

Early identification creates opportunities to study disease progression, distinguish between different forms of endometriosis, personalize treatment plans, and eventually develop therapies that target the underlying mechanisms rather than simply managing symptoms. Every earlier diagnosis contributes not only to better patient care today but also to a deeper understanding that benefits future generations of women.

Perhaps the most important shift, however, is cultural rather than technological. Women have spent generations questioning whether their pain was “bad enough” to deserve attention. When we validate symptoms early by confirming endometriosis, we don’t simply diagnose disease, we restore confidence, shorten years of uncertainty, and create the opportunity for healthier lives, healthier fertility journeys, and better outcomes across every stage of reproductive health.